Results 221 to 230 of about 990,536 (371)

Utilizing natriuretic peptides for predicting heart failure risk following myocardial infarction. [PDF]

Cardiovasc Endocrinol Metab
Ulziisaikhan G, Khurelbaatar MU, Khorloo C, Khasag A, Unurjargal T.   +4 more
europepmc   +1 more source

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A. [PDF]

Molecules, 2023
Vink S, Akondi KB, Jin J, Poth K, Torres AM, Kuchel PW, Burke SL, Head GA, Alewood PF.   +8 more
europepmc   +1 more source

Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.

, 1988
Dale C. Leitman, J W Andresen, Rosanne Catalano, Scott A. Waldman, J J Tuan, Ferid Murad   +5 more
openalex   +1 more source

Correction: Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting [PDF]

, 2011
Gregor Prosen, Petra Klemen, Matej Strnad, Štefek Grmec   +3 more
openalex   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure. [PDF]

Biomolecules
Charidemou E, Felekkis K, Papaneophytou C.   +2 more
europepmc   +1 more source

Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms. [PDF]

Int J Mol Sci, 2023
Gallo G, Rubattu S, Autore C, Volpe M.
europepmc   +1 more source

Degradation and clearance of atrial natriuretic factors [PDF]

, 1990
Adnot, Almeida, Anand-Srivastava, Anand-Srivastava, Anderson, Ando, Arendt, Arendt, Ballermann, Ballermann, Bates, Bertrand, Bianchi, Bianchi, Cachofeiro, Cantin, Cantin, Chartier, Chinkers, Cody, Crozier, De Bold, De Lean, Drexler, Espiner, Fethiere, Fulcher, Gerbes, Gerbes, Gerbes, Gines, Gros, Gutkowska, Hasegawa, Henriksen, Hinko, Hollister, Inagami, Kenny, Koehn, Koepke, Kollenda, Koseki, Krieter, Kurosawa, Lafferty, Laffi, Lang, Lang, Laragh, Leitman, Lieorens, Luft, Maack, Mantyh, Marumo, Masuda, Matsas, Matsas, Matsas, Misono, Murthy, Nakao, Needleman, Northridge, Olins, Olins, Olins, Pandey, Porter, Predel, Raine, Richards, Riegger, Saito, Scarborough, Schafferhans, Schiebinger, Schutten, Schwartz, Seymour, Shima, Sonnenberg, Stephenson, Stewart, Sudhir, Sugiyama, Sybertz, Sybertz, Takayanagi, Tamburini, Tang, Thibault, Trapani, Trapani, Trippodo, Vierhapper, Vollmar, Vollmar, Vollmar, Webb, Woods, Yukimura   +102 more
core   +1 more source

Effects of Natriuretic Peptides on the Centrally Mediated Pressor Response to Clonidine in Freely Moving Rats

, 1991
Shigeru Nakamura, Hiromu Kawasaki, Koichiro Takasaki   +2 more
openalex   +1 more source

Plasma Amino-Terminal Pro B-Type Natriuretic Peptide as a Predictor of Late Cardiovascular Mortality in Patients with Acute Lung Disorders: A Prospective, Observational Cohort Study [PDF]

, 2015
Heikki Koskela, Päivi Salonen, Jarkko Romppanen, Juha Hartikainen   +3 more
openalex   +1 more source